[1]
|
陈孝平, 汪建平. 第八版外科学[M]. 北京: 人民卫生出版社, 2013.
|
[2]
|
王锦姝, 王瑞康, 张鑫众, 王巍, 刘刚. 腹腔镜进展期胃癌根治术淋巴结检出数目的影响因素分析[J]. 中国普外基础与临床杂志, 2021, 28(6): 732-736.
|
[3]
|
Baiocchi, G.L., Kodera, Y., Marrelli, D., et al. (2014) Follow-Up after Gastrectomy for Cancer: Results of an International Web Round Table. World Journal of Gastroenterology, 20, 11966-11971.
https://doi.org/10.3748/wjg.v20.i34.11966
|
[4]
|
张恒, 何文玢, 何军, 焦增涛, 刘红岩. 医学知识增强的肿瘤分期多任务学习模型[J/OL]. 智能系统学报, 1-10.
http://kns.cnki.net/kcms/detail/23.1538.tp.20210330.1322.002.html, 2021-07-17.
|
[5]
|
饶鸿艳. 淋巴结转移率与胃癌根治术后患者预后的关系[D]: [硕士学位论文]. 福州: 福建医科大学, 2016.
|
[6]
|
胡祥, 张驰. 第15版日本《胃癌处理规约》拔萃[J]. 中国实用外科杂志, 2018, 38(5): 520-528.
|
[7]
|
刘文奇, 杜江. 胃癌切除术后淋巴结转移率与TNM分期系统对患者预后的影响比较[J]. 山西医药杂志, 2020, 49(22): 3119-3122.
|
[8]
|
Siewert, J.R., Btcher, K., Stein, H.J., et al. (1998) Relevant Prognostic Factors in Gastric Cancer: Ten-Year Results of the German Gastric Cancer Study. Annals of Surgery, 228, 449-461.
https://doi.org/10.1097/00000658-199810000-00002
|
[9]
|
李晨, 杜晓辉, 陈凛. 胃癌淋巴结转移率分期的研究现状[J]. 解放军医学院学报, 2014, 35(6): 634-636.
|
[10]
|
耿宏智. 影响进展期胃癌淋巴结转移率和转移数量分期的病理因素[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2013.
|
[11]
|
马志坚, 王科深, 任彦先, 焦作义. 淋巴结转移率对胃癌患者的预后价值[J]. 中国普外基础与临床杂志, 2020, 27(11): 1352-1356.
|
[12]
|
Sun, Z., Zhu, G.L., Lu, C., et al. (2009) The Impact of N-Ratio in Minimizing Stage Migration Phenomenon in Gastric Cancer Patients with Insufficient Number or Level of Lymph Node Retrieved: Results from a Chinese Mono-Institutional Study in 2 159 Patients. Annals of Oncology, 20, 897-905. https://doi.org/10.1093/annonc/mdn707
|
[13]
|
吴海滨, 张华秦, 谢辉, 刘勇. 淋巴结转移率与Ⅲ期胃癌患者D2根治术后生存率和化疗获益的关系研究[J]. 中国消化内科杂志2019, 27(5): 357-360+366.
|
[14]
|
尹杰, 蔡军, 张军, 郑智, 刘钊, 张忠涛. 早期胃癌淋巴结转移相关危险因素研究[J]. 中国实用外科杂志, 2016, 36(1): 111-114+118.
|
[15]
|
朱志, 杜雨薇, 刘福囝, 高鹏, 王振宁. 淋巴结转移在胃癌预后中的评价[J]. 腹部外科, 2021, 34(3): 179-183+188.
|
[16]
|
Saito, H., Fukumoto, Y., Osaki, T., et al. (2008) Prognostic Significance of the Ratio between Metastatic and Dissected Lymph Nodes (n Ratio) in Patients with Advanced Gastric Cancer. Journal of Surgical Oncology, 97, 132-135.
https://doi.org/10.1002/jso.20929
|
[17]
|
Kodera, Y., Yamamura, Y., Shimizu, Y., et al. (1998) Lymph Node Status Assessment for Gastric Carcinoma: Is the Number of Metastatic Lymph Nodes Really Practical as a Parameter for N Categories in the TNM Classification? Tumor Node Metastasis. Journal of Surgical Oncology, 69, 15-20.
https://doi.org/10.1002/(SICI)1096-9098(199809)69:1<15::AID-JSO4>3.0.CO;2-N
|
[18]
|
徐大志, 詹友庆, 李威, 周志伟, 陈映波, 孙晓卫, 陈功, 关远祥, 李元方. 阳性淋巴结转移率在胃癌D2术后的临床意义[C]//中国抗癌协会、中华医学会肿瘤学分会. 第五届中国肿瘤学术大会暨第七届海峡两岸肿瘤学术会议、国际肿瘤细胞与基因治疗学会会议、第二届中日肿瘤介入治疗学术会议论文集. 2008: 611-612.
|
[19]
|
肖隆斌, 杨世斌, 许峰峰, 黎文峰, 吴文辉, 李明哲. 淋巴结转移率对胃癌根治术后患者预后的评估价值[J]. 中华胃肠外科杂志, 2013(1): 56-59.
|
[20]
|
Kano, K., Yamada, T., Yamamoto, K., Komori, K., Watanabe, H., Hara, K., Shimoda, Y., Maezawa, Y., Fujikawa, H., Aoyama, T., Tamagawa, H., Yamamoto, N., Cho, H., Shiozawa, M., Yukawa, N., Yoshikawa, T., Morinaga, S., Rino, Y., Masuda, M., Ogata, T. and Oshima, T. (2020) Association between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer. Annals of Surgical Oncology, 27, 423.
https://doi.org/10.1245/s10434-020-08616-1
|
[21]
|
李良, 谢家存, 王志斌, 梁恒坡, 吴广银. 淋巴结转移率对Ⅲ期胃癌术后辅助放疗疗效的评估作用[J]. 中华放射医学与防护杂志, 2021, 41(5): 346-352.
|
[22]
|
Serrato, M. and Marian, A.J. (1995) A Variant of Human Paraoxonase/Arylesterase (HUMPONA) Gene Is a Risk Factor for Coronary Artery Disease. Journal of Clinical Investigation, 96, 3005-3008. https://doi.org/10.1172/JCI118373
|